ATYPICAL ENDOMETRIAL HYPERPLASIA
Clinical trials for ATYPICAL ENDOMETRIAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL ENDOMETRIAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for ATYPICAL ENDOMETRIAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial tests Two-Drug combo to fight uterine cancer without surgery
Disease control OngoingThis study is testing whether a hormone-releasing intrauterine device (IUD) works better alone or combined with an oral drug called everolimus to treat early-stage uterine cancer or a serious pre-cancerous condition. The goal is to see if this approach can control or eliminate th…
Matched conditions: ATYPICAL ENDOMETRIAL HYPERPLASIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Blueberry compound joins fight against uterine cancer
Disease control OngoingThis study is testing whether adding a natural antioxidant found in blueberries, called pterostilbene, to a standard hormone therapy (megestrol acetate) can better slow the growth of endometrial cancer. It involves 44 patients who are already scheduled for a hysterectomy. The goa…
Matched conditions: ATYPICAL ENDOMETRIAL HYPERPLASIA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC